Labrador, Mark Eleazar B.

HRN: 02-03-25  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2025
CEFTRIAXONE 1G (VIAL)
02/08/2025
02/15/2025
IV
2g
OD
Acute Uncomplicated Pyelonephritis; CAP-LR
Waiting Final Action 
02/08/2025
AZITHROMYCIN 500MG TABLET (TAB)
02/09/2025
02/11/2025
PO
500mg
OD
CAP-LR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: